Diabetes Prevention in the Vitamin D and Omega-3 Trial [ANCILLARY OF 700049031]
Latest Information Update: 02 Jun 2023
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms VITAL Diabetes
- 30 May 2023 Planned End Date changed from 1 Oct 2021 to 30 May 2024.
- 30 May 2023 Planned primary completion date changed from 1 Oct 2021 to 30 May 2024.
- 15 Nov 2021 Results presented at the American Heart Association Scientific Sessions 2021